For citations:
Samoilova A.G., Burmistrova I.A., Gaida A.I., Abramchenko A.V., Romanova M.I., Ryazhenov V.V. Gamma interferon in patients with drug-resistant pulmonary tuberculosis: clinical and cost-effectiveness aspects. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2026;1(19):24-33. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.359
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 